- Home
- ACXP vs SILO Comparison
ACXP vs SILO Comparison
Compare ACXP & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACXP
- SILO
- Stock Information
- Founded
- ACXP 2017
- SILO 2010
- Country
- ACXP United States
- SILO United States
- Employees
- ACXP N/A
- SILO N/A
- Industry
- ACXP Biotechnology: Pharmaceutical Preparations
- SILO Apparel
- Sector
- ACXP Health Care
- SILO Consumer Discretionary
- Exchange
- ACXP Nasdaq
- SILO Nasdaq
- Market Cap
- ACXP 6.8M
- SILO 5.9M
- IPO Year
- ACXP 2021
- SILO N/A
- Fundamental
- Price
- ACXP $4.12
- SILO $0.70
- Analyst Decision
- ACXP Strong Buy
- SILO
- Analyst Count
- ACXP 3
- SILO 0
- Target Price
- ACXP $143.67
- SILO N/A
- AVG Volume (30 Days)
- ACXP 67.3K
- SILO 941.5K
- Earning Date
- ACXP 11-12-2025
- SILO 11-11-2025
- Dividend Yield
- ACXP N/A
- SILO N/A
- EPS Growth
- ACXP N/A
- SILO N/A
- EPS
- ACXP N/A
- SILO N/A
- Revenue
- ACXP N/A
- SILO $72,102.00
- Revenue This Year
- ACXP N/A
- SILO $1.86
- Revenue Next Year
- ACXP N/A
- SILO N/A
- P/E Ratio
- ACXP N/A
- SILO N/A
- Revenue Growth
- ACXP N/A
- SILO N/A
- 52 Week Low
- ACXP $3.80
- SILO $0.41
- 52 Week High
- ACXP $44.00
- SILO $3.37
- Technical
- Relative Strength Index (RSI)
- ACXP 36.61
- SILO 54.08
- Support Level
- ACXP $4.09
- SILO $0.58
- Resistance Level
- ACXP $4.34
- SILO $0.83
- Average True Range (ATR)
- ACXP 0.45
- SILO 0.05
- MACD
- ACXP 0.10
- SILO 0.01
- Stochastic Oscillator
- ACXP 8.73
- SILO 48.39
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.